Tag: Capsule brittleness

Poor Flow Properties of Formulation Powders for Encapsulation Overcoming Poor Flow Properties of Formulation Powders for Encapsulation Context Powder flowability is a crucial factor in the encapsulation process, especially for hard gelatin capsules. Poor flow properties can lead to significant challenges in manufacturing, including inconsistent fill weights, dosage variations, and even production delays. Inconsistent powder…

Read More “Poor Flow Properties of Formulation Powders for Encapsulation” »

Issues with Achieving Desired Fill Weight Consistency for Hard Gelatin Capsules Overcoming Issues with Achieving Desired Fill Weight Consistency for Hard Gelatin Capsules Context Achieving consistent fill weight in hard gelatin capsules is a critical aspect of capsule manufacturing. Inconsistent fill weight can lead to variations in drug dosage, affecting the therapeutic efficacy of the…

Read More “Issues with Achieving Desired Fill Weight Consistency for Hard Gelatin Capsules” »

Difficulty in Incorporating Thermolabile APIs in Soft Gelatin Capsules Overcoming the Difficulty in Incorporating Thermolabile APIs in Soft Gelatin Capsules Context Thermolabile active pharmaceutical ingredients (APIs) are sensitive to heat and may degrade or lose their potency when exposed to high temperatures during manufacturing or storage. Incorporating these sensitive APIs into soft gelatin capsules presents…

Read More “Difficulty in Incorporating Thermolabile APIs in Soft Gelatin Capsules” »

Challenges in Creating Enteric-Coated Capsule Formulations Overcoming Challenges in Creating Enteric-Coated Capsule Formulations Context Enteric-coated capsules are designed to protect the active pharmaceutical ingredient (API) from the acidic environment of the stomach and ensure that it is released in the more neutral pH of the small intestine. This type of formulation is essential for drugs…

Read More “Challenges in Creating Enteric-Coated Capsule Formulations” »

Complexity in Developing Modified-Release Capsules Overcoming the Complexity in Developing Modified-Release Capsules Context Developing modified-release capsules presents significant challenges in pharmaceutical formulation due to the need for precise control over the release rate of the active pharmaceutical ingredient (API). Modified-release capsules are designed to release their contents in a controlled, delayed, or sustained manner, rather…

Read More “Complexity in Developing Modified-Release Capsules” »

Difficulty in Masking the Bitter Taste of Certain Drugs Overcoming the Challenge of Masking the Bitter Taste of Certain Drugs in Capsules Context Bitter-tasting active pharmaceutical ingredients (APIs) present a significant challenge in capsule formulation, especially for oral dosage forms. Many patients, particularly pediatric or geriatric populations, struggle with swallowing pills that have an unpleasant…

Read More “Difficulty in Masking the Bitter Taste of Certain Drugs” »

Limitations in Using Water-Sensitive APIs in Soft Gelatin Capsules Addressing the Limitations of Using Water-Sensitive APIs in Soft Gelatin Capsules Context Water-sensitive active pharmaceutical ingredients (APIs) pose significant challenges in soft gelatin capsule formulations. The hydrophilic nature of gelatin capsules makes them inherently sensitive to moisture, which can interact with water-sensitive APIs, leading to degradation,…

Read More “Limitations in Using Water-Sensitive APIs in Soft Gelatin Capsules” »

High Risk of Cross-Linking Reactions Between Gelatin and Aldehyde-Containing Drugs Addressing the High Risk of Cross-Linking Reactions Between Gelatin and Aldehyde-Containing Drugs in Capsule Formulations Context Cross-linking reactions between gelatin and aldehyde-containing drugs present a significant challenge in soft gelatin capsule formulations. Gelatin, as a natural polymer, contains amino acids with functional groups that can…

Read More “High Risk of Cross-Linking Reactions Between Gelatin and Aldehyde-Containing Drugs” »

Requirement for Specialized Coating to Prevent Gastric Degradation Addressing the Requirement for Specialized Coating to Prevent Gastric Degradation of Drugs in Capsule Formulations Context Some drugs are susceptible to degradation in the acidic environment of the stomach, which can result in reduced efficacy or harmful byproducts. To prevent gastric degradation, specialized coatings are required for…

Read More “Requirement for Specialized Coating to Prevent Gastric Degradation” »

Uneven Distribution of Low-Dose Drugs in the Powder Blend Addressing the Issue of Uneven Distribution of Low-Dose Drugs in the Powder Blend for Capsule Formulations Context Uneven distribution of low-dose drugs in powder blends is a common challenge faced during the formulation of capsule dosage forms. Achieving a uniform blend of the active pharmaceutical ingredient…

Read More “Uneven Distribution of Low-Dose Drugs in the Powder Blend” »

Development Challenges for Fixed-Dose Combination Products Overcoming the Development Challenges for Fixed-Dose Combination Products in Capsules Context Fixed-dose combination (FDC) products are commonly used in pharmaceutical formulations to improve patient adherence and optimize therapeutic outcomes. However, developing these products, especially in capsule form, presents unique challenges. FDCs involve combining two or more active pharmaceutical ingredients…

Read More “Development Challenges for Fixed-Dose Combination Products” »

Problems with Low Drug Loading in Soft Gelatin Capsules Addressing the Challenges of Low Drug Loading in Soft Gelatin Capsules Context Low drug loading in soft gelatin capsules is a significant challenge in pharmaceutical formulation, especially when working with drugs that require high precision in dosage. Low drug loading refers to the inability to incorporate…

Read More “Problems with Low Drug Loading in Soft Gelatin Capsules” »